OLD PROJECTS

Fungi in the setting of inflammation, allergy and autoimmune diseases: Translating basic science into clinical practices.
EIMID
European Institute of Microbiology and Infectious Diseases.
STAR-T REK
Set up and comparison of multiple stem cell approaches for kidney repair.
DEVANI
Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response.
EUROPRISE
European Vaccines and Microbicides Enterprise.
Network of excellence.
HEPACIVAC
New preventative and therapeutic Hepatitis C vaccines: from pre-clinical to phase 1.
CORMRA
Development of carbon monoxide releasing molecules for the treatment of rheumatoid arthritis.
EXERA
Development of 3D in vitro models of estrogen-reporter mouse tissues for the pharmaco-toxicological analysis of nuclear receptors-interacting compounds (NR-ICs).
FLUINNATE
Innate immunity in influenza virus infection of mammalian airways.
INNOCHEM
Innovative Chemokine-based Therapeutic Strategies for Autoimmunity and Chronic Inflammation.
ADIT
Design of small molecule therapeutics for the treatment of Alzheimer Disease based on the discovery of Innovative drug Targets.
MUVAPRED
MUcosal VAccines for Poverty RElated Diseases.
REBAVAC
Novel opportunities to develop VACcines to control antibiotic REsistant BActeria: from the trials back to the laboratory.
SARSVAC
Immunoprevention and immunotherapy of SARS infection.
EASYRING
Develop and validate novel non-invasive methods for the detection of known and new biomarkers of EDs directly in the mucus of aquatic species.
 
GLYCIDIC
New carbohydrate-derived scaffolds for the generation of bioactive libraries.
 
TFSS
Type IV secretion systems as targets for anti-infectious therapies.
 
INNAMORA
Novel Strategies of Mucosal Immunisation through Exploitation of Mechanisms of Innate Immunity in Pathogen-Host Interaction. Siena, Nov. 6-10, 2002.
 
MEMOVAX
Immunological memory and vaccination.
 
APOCLEAR
Novel therapeutic strategies for the treatment of human autoimmune diseases.
 
MUCIMM
European research groups excellent in mucosal immunology and vaccines were here integrated into a cluster.
 
MUCADJ
Mucosal administration of antigens is a global priority and is recommended by the 5th Framework Programme of the European Union.


back

   © 2010 ALTA S.r.l.u. - Via Fiorentina, 151 - 53100 Siena - Italy
   tel +39 0577 50518 fax +39 0577 593815
   e.mail: info@altaweb.eu
   capitale sociale € 10.845,00
   R.e.a 112828
   C.F. 12364330154 P.IVA 01033520527